Endotoxin administration to humans primes alveolar macrophages for increased production of inflammatory mediators

Academic Article


  • To elucidate potential mechanisms of the acute lung injury associated with endotoxemia, we evaluated the effect of intravenously administered endotoxin on the ability of alveolar macrophages isolated by bronchoalveolar lavage from normal subjects to produce inflammatory mediators. Within 1 hr of endotoxin (4 ng/kg body weight) administration, all 12 study subjects developed constitutional symptoms and leukopenia, and within 3 hr, lowgrade fever. Resolution of symptoms and fever by 6 hr was accompanied by systemic granulocytosis. Although intravenously administered endotoxin appeared to activate a subset of circulating monocytes, it did not alter the bronchoalveolar lavage cell number, phenotype (95% macrophages), or constitutively expressed high levels of surface HLA-DR and O2-. In contrast, intravenous endotoxin primed the alveolar macrophages for enhanced lipopolysaccharide-induced secretion of interleukin-1 (11.8 to 25.8 U/ml;P=0.04), tumor necrosis factor-α (titer, 6.8 to 13.6;P=0.20), and prostaglandin E2 (38.4 to 116.3 ng/ml;P=0.035). These results demonstrate that low-dose intravenous endotoxin primes human alveolar macrophages, which are already differentiated in situ, for enhanced secretion of inflammatory mediators. Such mediators may contribute to the pulmonary changes associated with endotoxemia and acute lung injury. © 1994 Plenum Publishing Corporation.
  • Published In

    Digital Object Identifier (doi)

    Author List

  • Smith PD; Suffredini AF; Allen JB; Wahl LM; Parrillo JE; Wahl SM
  • Start Page

  • 141
  • End Page

  • 148
  • Volume

  • 14
  • Issue

  • 2